Artificial intelligence for clinical research and diagnostics
Scailyte has raised €21M across 6 funding rounds from 3 investors, most recently a Series A round in Dec 2023. Based in Sursee, Switzerland; founded 2017; active in AI. Acquired by Hera Biotech in 2024. Data as of 7 Aug 2026.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-12-05 | Series A | €7.4M | — | View deal → |
| 2022-09-22 | Series A | €6.2M | — | View deal → |
| 2022-01-11 |
| Series A |
| — |
| — |
| View deal → |
| 2020-10-06 | Series A | €2.8M | Swisscom Ventures | View deal → |
| 2019-01-01 | Seed | €2.4M | Swisscom Ventures,Zürcher Kantonalbank ZKB | View deal → |
| 2018-12-20 | Seed | €2.4M | Swisscom Ventures,Venture Kick,Zürcher Kantonalbank ZKB | View deal → |
